The signifiance of any medical innovation is proportional to the prevalence of the health and medical problem it addresses and the potential disruption of current healthcare practices that innovation may bring about.
As 2/3 of the world's population is overweight, the burgeoning obesity problem forecast to affect 43% of us, and the obesity market projected to grow to $17 Trillion USD within a decade, the significance and impact of a safer and highly effective new treatment of obesity, metabolic syndrome and type 2 diabetes mellitus could not possibly be greater. It has the potential of improving the lives of 2.1 Billion people about the globe suffering from obesity and saving governments and society Trillions of dollars.
As industry research attests, the race is on for a solution! Here is a medical video depicting a promising solution under development for study, an Endoscopic Visceral Lipectomy procedure carried out on an obese patient with BioSculpture Technology, Inc.'s patented method and EVL® device.
25% of our children are already obese. An obese teen becomes an obese mother who has an obese child born with excessive visceral or "belly fat" pouring out noxious cytokines or cellular hormones responsible for all of the morbidities of obesity - sleep apnea and gastric reflux, hypertension, type 2 diabetes mellitus, heart attacks, strokes, angina, cancers, and autoimmune diseases! If we prevent that obese child from becoming an obese adolescent and obese mother with EVL, we can break the tightening obesity spiral in which more of our children become obese with each new generation.